Search Result "pacritinib/SB1518"


Metabolism and Disposition of Pacritinib (SB1518), an Orally Active Janus Kinase 2 Inhibitor in Preclinical Species and Humans

Journal: Drug Metabolism Letters
Volume: 9 Issue: 1 Year: 2015 Page: 28-47
Author(s): Ramesh Jayaraman,Mohammed Khalid Pasha,Anthony Williams,Kee Cee Goh,Kantharaj Ethirajulu

Biography free to download

Meet the Editorial Board Member

Journal: Current Drug Metabolism
Volume: 22 Issue: 10 Year: 2021 Page: 757-757
Author(s): R. Jayaraman

JAK Inhibitors: Pharmacology and Clinical Activity in Chronic Myeloprolipherative Neoplasms

Journal: Current Medicinal Chemistry
Volume: 20 Issue: 9 Year: 2013 Page: 1147-1161
Author(s): J. Trelinski,T. Robak

Second-Generation Protein Kinase Inhibitor – A Focus on Quizartinib, A Promising Targeted Therapy for High-Risk FLT3+ Patients with Acute Myeloid Leukemia

Ebook: Frontiers in Clinical Drug Research - Anti-Cancer Agents
Volume: 5 Year: 2019
Author(s): Xavier Thomas,Etienne Paubelle
Doi: 10.2174/9789811405150119050003

Biology and Clinical Management of Myeloproliferative Neoplasms and Development of the JAK Inhibitor Ruxolitinib

Journal: Current Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2012 Page: 4399-4413
Author(s): J. Mascarenhas, T. I. Mughal, S. Verstovsek

Current and Emerging Therapies in Primary Myelofibrosis

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 12 Issue: 1 Year: 2012 Page: 6-20
Author(s): Sabarish Ayyappan,Murali Janakiram,Radha Raghupathy

Review Article

JAK/STAT Signal Transduction: Promising Attractive Targets for Immune, Inflammatory and Hematopoietic Diseases

Journal: Current Drug Targets
Volume: 19 Issue: 5 Year: 2018 Page: 487-500
Author(s): Qianwen Gao,Xuewu Liang,Abdul Sami Shaikh,Jie Zang,Wenfang Xu,Yingjie Zhang

Designed Multiple Ligands: Basic Research vs Clinical Outcomes

Journal: Current Medicinal Chemistry
Volume: 19 Issue: 20 Year: 2012 Page: 3353-3387
Author(s): L. Costantino,D. Barlocco

Review Article

Developments of Fms-like Tyrosine Kinase 3 Inhibitors as AnticancerAgents for AML Treatment

Journal: Current Medicinal Chemistry
Volume: 31 Issue: 29 Year: 2024 Page: 4657-4686
Author(s):

Results 1 - 1 of 9

Apply Filters

Volume Years
Article Type
    Publication Title
      Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy